Skin Clique Company Profile

Background

Overview

Skin Clique is a physician-founded aesthetics company that offers personalized, medically-backed skincare services across the United States. Established in 2018, the company provides a range of treatments—including injectables, weight loss programs, hair growth solutions, skin treatments, and prescription skincare—through virtual consultations, in-home visits, and over 30 brick-and-mortar locations.

Mission and Vision

Skin Clique's mission is to make skin health a vital part of overall wellness by providing accessible, science-driven skincare solutions. The company envisions a future where expert skincare is available to everyone, regardless of location, through innovative delivery methods.

Industry Significance

Operating in the medical aesthetics industry, Skin Clique addresses the growing demand for convenient and personalized skincare treatments. By leveraging technology and a nationwide network of licensed providers, the company is redefining access to quality skincare services.

Key Strategic Focus

Core Objectives

Accessibility: Expand the reach of medical aesthetics by offering services in 42 states, making expert skincare available to a broader audience.

Personalization: Provide tailored skincare solutions through virtual consultations and in-home visits, ensuring treatments meet individual needs.

Education: Launch programs like the Esthetician Program to deliver science-backed product guidance and support patients in their skincare journeys.

Areas of Specialization

Injectables: Administer treatments such as Xeomin and Dysport for wrinkle relaxation.

Dermal Fillers: Offer products like Restylane, Juvederm, Radiesse, and Sculptra to restore facial volume.

Skin Treatments: Provide services including chemical peels and microneedling.

Weight Management: Implement GLP-1 weight loss medications, including compounded Semaglutide and Tirzepatide.

Hair Growth: Offer treatments to support hair restoration.

Prescription Skincare: Provide medical-grade skincare products for various skin concerns.

Key Technologies Utilized

Telemedicine Platforms: Facilitate virtual consultations and remote patient monitoring.

Mobile Applications: Enable appointment scheduling, patient education, and product purchases.

E-commerce Infrastructure: Support online sales of skincare products and treatment packages.

Primary Markets Targeted

Urban and Suburban Areas: Provide in-home and virtual services to residents seeking convenient skincare solutions.

Rural Communities: Expand access to medical aesthetics in underserved regions through virtual consultations.

Financials and Funding

Funding History

Skin Clique was acquired by Graham Healthcare Capital, a private equity firm, on January 1, 2022.

Total Funds Raised

Specific details regarding the total funds raised prior to the acquisition are not publicly disclosed.

Notable Investors

Graham Healthcare Capital: Private equity firm that acquired Skin Clique in 2022.

Utilization of Capital

The capital from the acquisition has been utilized to expand Skin Clique's services nationwide, enhance technological infrastructure, and support the development of new programs like the Esthetician Program.

Pipeline Development

Key Pipeline Candidates

Esthetician Program: Launched in May 2025, this program offers personalized, virtual skincare consultations to patients nationwide, integrating licensed estheticians into Skin Clique's care model.

Stages of Development

Esthetician Program: Currently operational, providing virtual consultations and product guidance to patients across 42 states.

Target Conditions

Esthetician Program: Aims to address a wide range of skincare concerns by offering personalized product recommendations and guidance.

Anticipated Milestones

Esthetician Program: Continued expansion and integration of estheticians into the care model to enhance patient access to expert skincare guidance.

Technological Platform and Innovation

Proprietary Technologies

Telemedicine Platforms: Customized systems for virtual consultations and patient management.

Mobile Applications: Developed in-house to facilitate patient engagement and service delivery.

Significant Scientific Methods

Evidence-Based Treatment Protocols: Utilize clinically validated methods for skincare treatments.

Data Analytics: Employ analytics to personalize treatment plans and monitor patient outcomes.

AI-Driven Capabilities

Treatment Personalization: Use AI algorithms to analyze patient data and recommend tailored skincare solutions.

Leadership Team

Key Executives

Dr. Sarah Allen, MD: Founder, CEO, and Chief Clinical Officer. Dr. Allen is a board-certified physician with extensive experience in medical aesthetics.

Claire O'Bryan, NP-C: Co-Founder and Nurse Practitioner. Ms. O'Bryan is a board-certified nurse practitioner specializing in aesthetic medicine.

Leadership Changes

Acquisition by Graham Healthcare Capital: On January 1, 2022, Skin Clique was acquired by Graham Healthcare Capital, leading to strategic shifts and expansion initiatives.

Competitor Profile

Market Insights and Dynamics

The medical aesthetics industry is experiencing significant growth, with a projected compound annual growth rate of 9.6% from 2022 to 2030. This expansion is driven by increasing consumer demand for non-invasive cosmetic procedures and personalized skincare solutions.

Competitor Analysis

Nu Skin Enterprises: A global company offering personal care products and dietary supplements through a network of independent distributors.

Dermalogica: A subsidiary of Unilever, providing professional-grade skincare products and education.

One Doc Medical: An award-winning laser treatment and aesthetic center in Malaysia, focusing on acne, pigmentation, and aging skin.

Strategic Collaborations and Partnerships

Graham Healthcare Capital: Acquired Skin Clique in 2022, providing capital and strategic guidance for expansion.

Operational Insights

Skin Clique differentiates itself by offering in-home, virtual, and in-office medical aesthetics services, making expert skincare accessible to a broader audience. The company's focus on personalized treatment plans and a comprehensive skin health approach sets it apart in the competitive landscape.

Strategic Opportunities and Future Directions

Strategic Roadmap

Expansion: Continue to grow the network of licensed providers to offer services in additional states.

Program Development: Enhance and expand programs like the Esthetician Program to provide more comprehensive skincare solutions.

Technology Integration: Invest in advanced technologies to improve patient engagement and treatment personalization.

Future Business Directions

Service Diversification: Introduce new treatments and services based on emerging skincare trends and patient needs.

Global Expansion: Explore opportunities to offer services internationally, leveraging the success of the current business model.

Opportunities for Expansion

Partnerships: Collaborate with healthcare providers and wellness centers to expand service offerings.

Product Line Extension: Develop proprietary skincare products to complement existing services.

Positioning for Future Objectives

Skin Clique's commitment to accessible, personalized, and science-backed skincare positions it well to achieve its future objectives and continue to lead in the medical aesthetics industry.